PANCREAZE

VIVUS LLC🇺🇸 United States

FDA Page

Effective Date: Mar 19, 2024
Approval ID: e8f5d2fe-728d-42af-99a6-83dddc6539c5
Products: 0 registered
Version: 15

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"sup": ["®", "®", "®"], "br": [null, null], "#text": "These highlights do not include all the information needed to use PANCREAZE \n safely and effectively. See full prescribing information for PANCREAZE \n .\n \nPANCREAZE \n (pancrelipase) delayed-release capsules\n \nInitial U.S. Approval: 2010"}

Quick Stats

Total Products0

Labelers1

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.